ENTA - Enanta Pharma GAAP EPS of -$1.86 beats by $0.47 revenue of $18.89M beats by $2.15M August, 07 2023 04:02 PM Enanta Pharmaceuticals Inc. 2023-08-07 16:02:32 ET Enanta Pharma press release ( NASDAQ: ENTA ): Q3 GAAP EPS of -$1.86 beats by $0.47 . Revenue of $18.89M (-3.0% Y/Y) beats by $2.15M . For further details see: Enanta Pharma GAAP EPS of -$1.86 beats by $0.47, revenue of $18.89M beats by $2.15M